The Digital Health market encompasses a broad scope of technologies that range from mobile health apps to connected wearable devices to telemedicine. The ubiquitous use of the internet and smartphones along with the shifting tendency towards healthier lifestyles and increased well-being have sparked a significant growth in this market. The COVID-19 pandemic has positively accelerated growth in the Digital Health market by making healthcare and self-monitoring of health conditions more accessible to public. With Digital therapeutics slowing becoming mainstream with regulatory approvals and reimbursement routes established, this market is estimated to significantly grow in the coming years.
industries
|
Pharma, Medical & Biotech (Healthcare)
Digital Health & HealthTech
— Statista
Revenue
Select Advertising M&A Transactions
Exitwise has catalogued the most relevant M&A transactions that our industry specialized, M&A experts have completed. Feel free to search through our transaction catalogue, or better yet,Contact Usto request a list of the most relevant exits from your industry.
sold
GeneMatters
pharma, medical, & biotech — Digital Health & HealthTech
GeneMatters is a leading provider of telehealth genetic counseling and software solutions to increase access to genetic services. They deliver customizable solutions to hospitals, health networks, genetic testing labs and biopharmaceutical organizations to extend the capacity of existing genetic counseling teams, support new programs and increase patient engagement with genetic services. Their genetic expertise spans oncology, reproductive, cardiovascular and rare diseases. Founded in 2016 by Jill Davies, a genetic counselor, with a mission to increase patient access, they are committed to outstanding service delivery, unwavering quality standards, high patient satisfaction and technology to simplify care.
Acquired by Genome Medical
sold
Insignia Health
pharma, medical, & biotech — Digital Health & HealthTech
Insignia Health aims to help everyone become a better manager of their own health and healthcare. To accomplish this goal, they empower healthcare professionals and organizations around the world with the tools and strategies to improve patient activation. This behavioral health model is anchored by the Patient Activation Measure® (PAM®) and their portfolio of validated activation measures. Over two decades of health research and PAM’s® practical application show that as patient activation increases, preventable utilization and costs decrease while health outcomes improve.
Acquired by Phreesia
sold
Iris Healthcare
pharma, medical, & biotech — Digital Health & HealthTech
Austin, Texas-based Iris Healthcare provides advance care planning technology solutions, and Aledade will fold the company's technology into its new health services unit, called Aledade Care Solutions, the company said.
Acquired by Aledade
sold
Sayana
pharma, medical, & biotech — Digital Health & HealthTech
Sayana’s Self-Care app uses chat sessions with an AI dubbed Sayana that tracks their feelings and connects them to their experiences and actions. It also offers different content and exercises, depending on the information a user provides and their mood trends. It also has a self-care app geared toward the employer market for managing stress and anxiety. Sayana’s Sleep app tracks when users go to sleep and how they feel. It also offers guided sessions and soundscapes to help them fall asleep.
Acquired by Headspace Health